Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA for Fluorescence-guided Resection of Malignant Gliomas
NCT02755142Phase 2Completed
- Sponsor
- medac GmbH
- Start
- Feb 2000
- Primary completion
- Jun 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in malignant glioma, sponsored by medac GmbH. Started Feb 2000; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT02755142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02755142.